COCH vs MLSS: stock comparison and AI forecast
Envoy Medical, Inc. (COCH) and Milestone Scientific Inc. (MLSS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
COCH Envoy Medical, Inc.
- Market Cap
- $55M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MLSS Milestone Scientific Inc.
- Price
- $0.30 -36.2% · 6M
- Market Cap
- $27M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- COCH is 2.1 times larger than MLSS by market capitalization ($55M against $27M).
- MLSS turns -35.6% of its revenue into net income, against -8781.3% for COCH.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | COCH | MLSS |
|---|---|---|
| Market Cap | $55M | $27M |
| P/B Ratio | – | 7.65x |
| EPS | $-3.90 | $-0.08 |
| Book Value/Share | – | $0.04 |
| Revenue/Share | $0.03 | $0.13 |
| FCF/Share | – | $-0.01 |
Profitability & Margins
| Metric | COCH | MLSS |
|---|---|---|
| ROE | – | -119.4% |
| ROA | – | -49.6% |
| ROIC | – | -154.4% |
| Gross Margin | -271.7% | 70.9% |
| Operating Margin | -7816.7% | -52.4% |
| Net Margin | -8781.3% | -35.6% |
| EBT Margin | -8312.0% | -52.7% |
Financial Health
| Metric | COCH | MLSS |
|---|---|---|
| Current Ratio | 1.21x | 1.85x |
| Quick Ratio | 1.10x | 1.14x |
| D/E Ratio | – | 1.41x |
| Financial Leverage | – | 2.41x |
| Interest Coverage | -291.4x | -310.1x |
| Working Capital | $3M | $4M |
Cash Flow
| Metric | COCH | MLSS |
|---|---|---|
| Operating Cash Flow | -$22M | -$640K |
| Free Cash Flow | – | -$660K |
| Capital Spending | – | -$20K |
| FCF/Sales | – | -5.7% |
| CapEx/Sales | – | 0.2% |
Operational Efficiency
| Metric | COCH | MLSS |
|---|---|---|
| Asset Turnover | – | 1.40x |
| Receivables Turnover | 4.5x | – |
| Inventory Turnover | 0.7x | 1.1x |
| Fixed Assets Turnover | 0.3x | 579.0x |
| Days Sales Outstanding | 81 days | – |
| Days Inventory | 527 days | 332 days |
| Payables Period | 552 days | – |
| Cash Conversion Cycle | 55 days | – |
Income Statement
| Metric | COCH | MLSS |
|---|---|---|
| Total Revenue | $230K | $12M |
| Operating Income | -$23M | -$6M |
| Net Income | -$26M | -$4M |
| R&D Expense | $14M | $460K |
| SG&A Expense | $10M | $14M |
| Cost of Goods Sold | $1M | $3M |
Dividend & Shareholder Information
| Metric | COCH | MLSS |
|---|---|---|
| Shares Outstanding | 8M | 89M |
COCH vs MLSS: stock comparison and AI forecast
Which is bigger, COCH or MLSS?
COCH is 2.1 times larger than MLSS by market capitalization ($55M against $27M).
Which one does Intratio's AI model rank higher, COCH or MLSS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.